Annual Shareholders Equity
$512.23 M
-$154.65 M-23.19%
December 31, 2023
Summary
- As of February 7, 2025, ALLO annual stockholders equity is $512.23 million, with the most recent change of -$154.65 million (-23.19%) on December 31, 2023.
- During the last 3 years, ALLO annual shareholders equity has fallen by -$567.38 million (-52.55%).
- ALLO annual shareholders equity is now -52.55% below its all-time high of $1.08 billion, reached on December 31, 2020.
Performance
ALLO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$463.75 M
-$51.29 M-9.96%
September 30, 2024
Summary
- As of February 7, 2025, ALLO quarterly stockholders equity is $463.75 million, with the most recent change of -$51.29 million (-9.96%) on September 30, 2024.
- Over the past year, ALLO quarterly shareholders equity has dropped by -$119.35 million (-20.47%).
- ALLO quarterly shareholders equity is now -60.14% below its all-time high of $1.16 billion, reached on June 30, 2020.
Performance
ALLO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ALLO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.2% | -20.5% |
| 3 y3 years | -52.5% | -42.2% |
| 5 y5 years | -27.1% | -25.2% |
ALLO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.6% | at low | -49.9% | +0.5% |
| 5 y | 5-year | -52.5% | at low | -60.1% | +0.5% |
| alltime | all time | -52.5% | >+9999.0% | -60.1% | +375.3% |
Allogene Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $463.75 M(-10.0%) |
| Jun 2024 | - | $515.04 M(+11.6%) |
| Mar 2024 | - | $461.37 M(-9.9%) |
| Dec 2023 | $512.23 M(-23.2%) | $512.23 M(-12.2%) |
| Sep 2023 | - | $583.10 M(-6.4%) |
| Jun 2023 | - | $622.91 M(+5.2%) |
| Mar 2023 | - | $592.26 M(-11.2%) |
| Dec 2022 | $666.88 M(-27.9%) | $666.88 M(-9.9%) |
| Sep 2022 | - | $739.96 M(-7.7%) |
| Jun 2022 | - | $801.95 M(-6.2%) |
| Mar 2022 | - | $855.23 M(-7.6%) |
| Dec 2021 | $925.20 M | $925.20 M(-4.6%) |
| Sep 2021 | - | $969.94 M(-5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $1.02 B(-4.3%) |
| Mar 2021 | - | $1.07 B(-0.9%) |
| Dec 2020 | $1.08 B(+71.6%) | $1.08 B(-3.5%) |
| Sep 2020 | - | $1.12 B(-3.8%) |
| Jun 2020 | - | $1.16 B(+91.8%) |
| Mar 2020 | - | $606.52 M(-3.6%) |
| Dec 2019 | $629.02 M(-10.5%) | $629.02 M(+1.5%) |
| Sep 2019 | - | $619.72 M(-5.5%) |
| Jun 2019 | - | $655.63 M(-3.8%) |
| Mar 2019 | - | $681.23 M(-3.1%) |
| Dec 2018 | $703.16 M(<-9900.0%) | $703.16 M(-517.4%) |
| Sep 2018 | - | -$168.44 M(-159.8%) |
| Jun 2018 | - | $281.61 M |
| Dec 2017 | -$2000.00 | - |
FAQ
- What is Allogene Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Allogene Therapeutics?
- What is Allogene Therapeutics annual shareholders equity year-on-year change?
- What is Allogene Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly shareholders equity year-on-year change?
What is Allogene Therapeutics annual stockholders equity?
The current annual shareholders equity of ALLO is $512.23 M
What is the all time high annual shareholders equity for Allogene Therapeutics?
Allogene Therapeutics all-time high annual stockholders equity is $1.08 B
What is Allogene Therapeutics annual shareholders equity year-on-year change?
Over the past year, ALLO annual stockholders equity has changed by -$154.65 M (-23.19%)
What is Allogene Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of ALLO is $463.75 M
What is the all time high quarterly shareholders equity for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly stockholders equity is $1.16 B
What is Allogene Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, ALLO quarterly stockholders equity has changed by -$119.35 M (-20.47%)